{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:56:44Z","timestamp":1791597404930,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Programmed Death Ligand 1 (PD-L1) expression in tumor cells contribute to tumor immunity and therapies directed against it, have shown encouraging results in recent years. As there is limited data on the significance of PD-L1 expression in Head and Neck Squamous Cell Carcinoma (HNSCC) from India, we aimed to study the PD-L1 expression and its relation with different clinic-pathological parameters in patients of HNSCC from a tertiary care center in Eastern India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective evaluation of HNSCC patients diagnosed and managed at our center over a period of two and half years, was performed. PD-L1 expression in formalin fixed-paraffin embedded tumor tissue specimens was measured using SP-263 (Ventana) and 22C3 (Dako). A PD-L1 expression of &lt;1%, 1\u201319%, \u226520% were considered negative, low, and high expression, respectively, and was correlated with various parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 71 patients (mean age 50.8 \u00b1 13.3 years, 86% males) were diagnosed with HNSCC (buccal mucosa-28, tongue-22, rest of oral cavity-8, larynx-7, nasopharynx-6). The tumor was poorly differentiated in 12 (17%). PD-L1 positivity was seen in a total of 51 (71.8%) patients (1\u201319%:18, \u226520%:33). Thirty (85.7%) patients among those aged &lt;50 years and 58.3% of those aged \u226550 years showed PD-L1 positivity which was significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01). There were no statistically significant differences in PD-L1 positivity with respect to gender, tobacco use, tumor grade as well as tumor and nodal stage. Median follow up duration was 18 months (range 3\u201331 months) and there was significant difference in overall survival among PD-L1 positive and negative groups (31 vs 24 months; log rank\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>72% of HNSCC patients in our cohort showed PD-L1 positivity and it was not associated with any patient demographic characteristics or aggressive pathological features. Positive PD-L1 expression may have a beneficial effect on overall survival in HNSCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1239_22","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T15:00:51Z","timestamp":1711810851000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["PD-L1 expression in head and neck squamous cell carcinoma and its clinical significance: A prospective observational study from a tertiary care centre"],"prefix":"10.4103","volume":"20","author":[{"given":"Sindhu","family":"Kilaru","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya Surath","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalatendu","family":"Moharana","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debahuti","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Department of Pathology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya Sundar G.","family":"Mohapatra","sequence":"additional","affiliation":[{"name":"Department of Radiology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adyakinkar","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Radiology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spoorthy","family":"Kolluri","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Devaraj","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Kabi","sequence":"additional","affiliation":[{"name":"Department of Pathology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sparsh Hospital and Critical care, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghanashyam","family":"Biswas","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, IMS and SUM Hospital, SOA University, Bhubaneswar, Odisha, India"},{"name":"Department of Medical Oncology, Sparsh Hospital and Critical care, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"R1-20260507","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260507","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/ijc.30608","article-title":"Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer","volume":"140","author":"Anantharaman","year":"2017","journal-title":"Int J Cancer"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12916-019-1453-z","article-title":"Can public health policies on alcohol and tobacco reduce a cancer epidemic? Australia\u2019s experience","volume":"17","author":"Jiang","year":"2019","journal-title":"BMC Med"},{"key":"R5-20260507","journal-title":"Cancer today"},{"key":"R6-20260507","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.coms.2018.09.003","article-title":"Current concepts in chemotherapy for head and neck cancer","volume":"31","author":"Sindhu","year":"2019","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R7-20260507","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"R8-20260507","first-page":"401","article-title":"Oral cavity and oropharyngeal squamous cell carcinoma--An update","volume":"65","author":"Chi","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R9-20260507","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"R11-20260507","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.30770","article-title":"The PD-1\/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)","volume":"141","author":"Balermpas","year":"2017","journal-title":"Int J Cancer"},{"key":"R13-20260507","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/0008-5472.CAN-12-2384","article-title":"Evidence for a role of the PD-1: PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma","volume":"73","author":"Lyford-Pike","year":"2013","journal-title":"Cancer Res"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4143\/crt.2015.249","article-title":"Association between PD-L1 and HPV status and the prognostic value of PD-L1 in oropharyngeal squamous cell carcinoma","volume":"48","author":"Kim","year":"2016","journal-title":"Cancer Res Treat"},{"key":"R15-20260507","journal-title":"VENTANA PD-L1 (SP263) Assay (CE IVD). Diagnostics"},{"key":"R16-20260507","doi-asserted-by":"crossref","first-page":"e0183023","DOI":"10.1371\/journal.pone.0183023","article-title":"Use of the 22C3 anti\u2013PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms","volume":"12","author":"Ilie","year":"2017","journal-title":"PLoS One"},{"key":"R17-20260507","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41379-020-00710-9","article-title":"Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer","volume":"34","author":"Emancipator","year":"2021","journal-title":"Mod Pathol"},{"key":"R18-20260507","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41416-019-0449-y","article-title":"Intratumor heterogeneity of PD-L1 expression in head and neck squamous cell carcinoma","volume":"120","author":"Rasmussen","year":"2019","journal-title":"Br J Cancer"},{"key":"R19-20260507","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/cancers13020292","article-title":"PD-L1 Testing and squamous cell carcinoma of the head and neck: A multicenter study on the diagnostic reproducibility of different protocols","volume":"13","author":"Crosta","year":"2021","journal-title":"Cancers"},{"key":"R20-20260507","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.oraloncology.2005.07.013","article-title":"Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma","volume":"42","author":"Tsushima","year":"2006","journal-title":"Oral Oncol"},{"key":"R21-20260507","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"R22-20260507","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3389\/fimmu.2020.01721","article-title":"The evolving landscape of PD-1\/PD-L1 pathway in head and neck cancer","volume":"11","author":"Qiao","year":"2020","journal-title":"Front Immunol"},{"key":"R23-20260507","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"R24-20260507","doi-asserted-by":"crossref","first-page":"77010","DOI":"10.18632\/oncotarget.12776","article-title":"PD-L1 expression in tonsillar cancer is associated with human papillomavirus positivity and improved survival: Implications for anti-PD1 clinical trials","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"key":"R25-20260507","doi-asserted-by":"crossref","first-page":"e1341030","DOI":"10.1080\/2162402X.2017.1341030","article-title":"Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV\/p16 in head and neck cancer treated with bio- or chemo-radiotherapy","volume":"6","author":"Ou","year":"2017","journal-title":"OncoImmunology"},{"key":"R26-20260507","article-title":"Determining PD-L1 expression in head and neck squamous cell carcinoma using immunohistochemistry","author":"Mishra","year":"2021","journal-title":"Indian J Cancer"},{"key":"R27-20260507","doi-asserted-by":"crossref","first-page":"e0142656","DOI":"10.1371\/journal.pone.0142656","article-title":"High PD-L1 expression correlates with metastasis and poor prognosis in oral squamous cell carcinoma","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"R28-20260507","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/hed.25713","article-title":"Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinoma","volume":"41","author":"Moratin","year":"2019","journal-title":"Head Neck"},{"key":"R29-20260507","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","article-title":"Clinical significance of PD-L1+exosomes in plasma of head and neck cancer patients","volume":"24","author":"Theodoraki","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R30-20260507","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.oraloncology.2011.08.007","article-title":"Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma","volume":"47","author":"Cho","year":"2011","journal-title":"Oral Oncol"},{"key":"R31-20260507","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12105-012-0406-z","article-title":"B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma","volume":"7","author":"Ukpo","year":"2013","journal-title":"Head Neck Pathol"},{"key":"R32-20260507","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hed.25507","article-title":"Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity","volume":"41","author":"Ryu","year":"2019","journal-title":"Head Neck"},{"key":"R33-20260507","doi-asserted-by":"crossref","first-page":"152768","DOI":"10.1016\/j.prp.2019.152768","article-title":"The different role of PD-L1 in head and neck squamous cell carcinomas: A meta-analysis","volume":"216","author":"Tang","year":"2020","journal-title":"Pathol Res Pract"},{"key":"R34-20260507","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejca.2017.05.026","article-title":"Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review","volume":"82","author":"Hussein","year":"2017","journal-title":"Eur J Cancer"},{"key":"R35-20260507","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","article-title":"Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers","volume":"31","author":"Chaturvedi","year":"2013","journal-title":"J Clin Oncol"},{"key":"R36-20260507","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/hed.22935","article-title":"Oral and oropharyngeal squamous cell carcinoma in young patients: The Netherlands Cancer Institute experience","volume":"35","author":"van Monsjou","year":"2013","journal-title":"Head Neck"},{"key":"R37-20260507","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oraloncology.2018.09.016","article-title":"The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis","volume":"86","author":"Yang","year":"2018","journal-title":"Oral Oncol"},{"key":"R38-20260507","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1724600819884722","article-title":"Expression of PD-1\/PD-L1 in head and neck squamous cell carcinoma and its clinical significance","volume":"34","author":"Chen","year":"2019","journal-title":"Int J Biol Markers"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1239_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:48Z","timestamp":1787067588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_1239_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1239_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"2022-06-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}